Gómez JP, Leal HM, Abellán AJ, Lozano SML, Hernández MF, García-Galbis MJA, Martínez PA

Language: Spanish
References: 12
Page: 101-102
PDF size: 47.70 Kb.

ABSTRACT

Objective: 1) To identify the state of renal function in the hypertensive patient without diabetes followed habitually by means of consultation with a primary-care physician, and 2) to know the incidence of hidden renal illness in these patients. Material and Methods: Cross-sectional and descriptive study. The selected sample was composed of 102 patients diagnosed with high blood pressure without diabetes, who were followed-up habitually in consultations provided by the Arterial Hypertension Program. The following variables were recognized: Age; sex; weight; height; body mass index (BMI); waist circumference; measurements of the most recent three blood pressure (BP) determinations (systolic and diastolic); other cardiovascular-risk factors; creatinine in plasma, and albumin/creatinine index in urine sample. Renal function evaluation was completed by means of estimating creatinine clearance through use of the abbreviated Crockroft-Gault formula. Results: A total of 34.31% of patients (35 patients) showed a creatinine clearance of › 60 ml/min; 31 of these 26 patients exhibited normal had a blood creatinine. . Creatinine clearance was ‹ 90 ml/min in 11.76% of patients (12 patients). Prevalence of hidden renal disease was present in 29.41% of patients (30 patients). BP showed figures of › 140/90 mmHg Hg in 18 patients (17.65%). This was ‹ 120/80 mmHg in 24 patients (23.6% of patients). Sixty patients (58.8% of patients) showed numbers between 120/80 and 140/90 mmHg. (58.8%). Conclusions: The prevalence of hidden renal illness is important. Nearly one third of the hypertensive patients in our work presented chronic stage-3 renal disease.High Blood Pressure in the Patient Without Diabetes.

REFERENCES

1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Supl. 1): S46-S75.

2. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of Chronic Kidney Disease and decreased kidneyfunction in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Disease 2003; 41: 1-12.

3. Chadban SJ, Briganti EM, Kerr PG. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003; 14 (Supl. 2): S131-8.

4. Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 2001; 16: 1042-6.

5. Fernández-Fresnedo G, de Francisco AL, Rodrigo E. «Occult» renal insufficiency due to evaluating renal function using only serum creatinina. Nefrología 2002; 22: 144-51.

6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.

7. Levey AS, Bosch JP, Lewis JB. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.

8. Brown WW, Collins A, Chen SC. Identification of persons at high risk for kidney disease via targeted screening: the NKF Kidney Early Evaluation Program. Kidney Int 2003;(Supl.) 83: S50-5.

9. Simal F, Martín Escudero JC, Bellido J. Prevalence of mild to moderate chronic kidney disease in the general population of Spain. Hortega study. Nefrología 2004; 24: 329-32.

10. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(12 Supl.): S16-23.

11. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-305.

12. Anavekar NS, McMurray JJ, Velázquez EJ. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-95.